Order reprints

Open Access

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

Robert Eggertsen*, Åke Andreasson and Lennart Andrén

BMC Pharmacology and Toxicology 2012, 13:10  doi:10.1186/2050-6511-13-10

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required

http://www.biomedcentral.com/2050-6511/13/10
2050-6511-13-10